Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N MUKHERJEE

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Indian Medical Journal|March 19, 2010
Acute diarrhoea among infants during summer months at Jamshedpur and suburbsD N MUKHERJEE
Indian Medical Journal|October 29, 2010
Infant feedingD N MUKHERJEE
Indian Journal of Medical Microbiology|November 6, 2020
Assessment of antibacterial activity of levonadifloxacin against contemporary gram-positive clinical isolates collected from various Indian hospitals using disk-diffusion assayShrikala Baliga, Dhruv K Mamtora, Varsha Gupta, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Indian Medical Journal|March 19, 2010
Acute diarrhoea among infants during summer months at Jamshedpur and suburbsD N MUKHERJEE
Indian Medical Journal|October 29, 2010
Infant feedingD N MUKHERJEE
Indian Journal of Medical Microbiology|November 6, 2020
Assessment of antibacterial activity of levonadifloxacin against contemporary gram-positive clinical isolates collected from various Indian hospitals using disk-diffusion assayShrikala Baliga, Dhruv K Mamtora, Varsha Gupta, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2019
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Pageof 1